Mastering Antibody Development! Are you working in the biotech space? Whether you’re in research, development, or management, knowing the right practices can set you apart! Let's start the week by highlighting the Key Dos and Don'ts to Remember! Curious for more? Follow us for updates! #AntibodyDevelopment #Biotech #Innovation #SilicaCorpora
Silica Corpora
Biotechnologieforschung
In Silica Corpora we design the next generation of Antibody Therapeutics using Generative AI
Info
Design, not Discovery. We Design Antibody Drug Candidates with AI to allow Lead Generation in Days, not Years.
- Website
-
https://www.silica-corpora.tech
Externer Link zu Silica Corpora
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Berlin
- Art
- Privatunternehmen
- Gegründet
- 2022
- Spezialgebiete
- Artificial Intelligence, Drug Discovery, Protein Design, Deep Learning und Antibody Design
Orte
-
Primär
Berlin, 10243, DE
Beschäftigte von Silica Corpora
-
Tim Ermak
-
Jaime Rossello Coll
CEO & Co-founder of @Silica Corpora | Berkeley SkyDeck Batch 16 | Nucleate Activator
-
Dima Al-Hilfi
| Biomedical Engineer | Marketing assistant at HTW Berlin | Current master student in MBA & Engineering in Life Science Management Programme, HTW…
Updates
-
Silica Corpora hat dies direkt geteilt
Why Invest in Therapeutic Antibody Market??? The Numbers Don’t Lie! The global therapeutical antibody market offers a remarkable investment opportunity, valued at 247.3 billion in 2023 and projected to reach 479 billion by 2028, with a strong compound annual growth rate ( CAGR) of 14.1% during the 2023-2028 period. This impressive growth is fueled by innovations in antibody engineering and expanding applications in oncology, immunology, and infectious diseases, including key breakthroughs in COVID-19 treatments. With these numbers in mind, Now is the best time to invest in this fast growing market. #TherapeuticAntibodies #SilicaCorpora #LifeSciences #PharmaTech #AI #InvestInHealth
-
Why Invest in Therapeutic Antibody Market??? The Numbers Don’t Lie! The global therapeutical antibody market offers a remarkable investment opportunity, valued at 247.3 billion in 2023 and projected to reach 479 billion by 2028, with a strong compound annual growth rate ( CAGR) of 14.1% during the 2023-2028 period. This impressive growth is fueled by innovations in antibody engineering and expanding applications in oncology, immunology, and infectious diseases, including key breakthroughs in COVID-19 treatments. With these numbers in mind, Now is the best time to invest in this fast growing market. #TherapeuticAntibodies #SilicaCorpora #LifeSciences #PharmaTech #AI #InvestInHealth
-
Did You Know?? The Return on Investment (ROI) for drug development has dramatically decreased from 10.1% in 2010 to just 1.9% in 2018. This significant drop can be attributed to several factors: - Limited Understanding of Disease Mechanisms: Insufficient knowledge of how illnesses develop complicates the design of drugs that effectively target actionable genes while minimizing adverse side effects. - Optimization Challenges: Achieving the right balance in antibody properties, such as binding affinity, specificity, and pharmacokinetics, is crucial for drug efficacy and efficient delivery. We invite you to explore how our AI-driven platform enhances the precision, predictability, and speed of drug discovery. Together, we can address these challenges and advance the future of drug development #PharmaROI #DrugDevelopment #DrugDiscovery #SilicaCorpora #AI #Innovation
-
Overcoming Challenges in Drug Discovery!! The path to developing new therapies is long, intricate, and expensive, with numerous obstacles standing in the way. Among these challenges are rising R&D costs, limitations in existing modelling techniques, and gaps in understanding the complex disease mechanisms—all of which progress in drug discovery. As research evolves and new modelling technologies emerge, pivotal questions arise: ⏺ How is the industry tackling these challenges? ⏺ Are current strategies truly making a difference? Join us on our journey to to transforming the drug discovery process, making it faster, more precise, and better equipped to identify promising candidates. #DrugDiscovery #BioTech #AI #DrugDesign #SilicaCorpora
-
New Design, more information, same vision. Our redesigned website is live and better than ever! Explore the upgraded features and the new version now, including our updated modules with their case studies, our detailed vision for cooperations and partnerships and our most updated whitepapers: https://lnkd.in/dZQTA5cB #NewWebsite #DrugDesign #SilicaCorpora #TogetherForBetter
-
Calling All Biotech and Pharmaceutical Professionals! We want to hear from you! How long does it typically take to bring a new drug to market? Cast your vote in our poll and let’s see how industry experts perceive the timeline for drug development! #Biotech #DrugDevelopment #SilicaCorpora #AI #PharmaTimeline
Dieser Inhalt ist hier nicht verfügbar.
Mit der LinkedIn App können Sie auf diese und weitere Inhalte zugreifen.
-
Join us in Welcoming Dima!! 🚀 We're excited to introduce Dima Al-Hilfi, our new Market Intern! who brings a unique blend of skills and experience to our team! With a background as a Biomedical Engineer and three years of experience in sales and marketing, Dima Al-Hilfi is currently pursuing an MBA and Engineering in Life Science Management. Welcome, Dima we can’t wait to see the amazing things you’ll achieve with us! #WelcomeToTheTeam #MarketIntern #SilicaCorpora #Teamwork
-
Pitching for the Future! We’re excited to share the highlights of our pitch journey at Berlin’s biggest startup gathering, supported by Dell Technologies! From presenting our groundbreaking solution to gaining expert insights, this journey was packed with inspiration, learning, and incredible feedback. Thank you for being part of this Journey. Together, we’re shaping the future of the next generation of Antibody Therapeutics . #PitchPresentation #ProfessionalDevelopment #Biotech #SilicaCorpora #delltechnologies #DDX
-
Today marks a major milestone – Silica Corpora’s 2-year anniversary! We started with a vision, and thanks to the dedication, passion, and hard work of our incredible team, We've been around for two years now. And this is only the beginning. We are grateful to all our page members and supporters who have been part of our journey. Your belief in us has been key to our growth and success! #Anniversary #SilicaCorpora #Teamwork #Innovation #FutureofHealthcare